News about Outsourcing

Advantage eClinical, a cloud platform to empower biotech companies and CROs with an integrated solution for clinical data management

Advantage eClinical, a cloud platform to empower biotech companies and CROs with an integrated solution for clinical data management

Advantage eClinical provides a fully integrated suite of data management applications.

Outsourcing | 17/05/2022 | By Content editor

Glenmark's subsidiary, Ichnos Sciences signs licensing pact with Almirall

Glenmark's subsidiary, Ichnos Sciences signs licensing pact with Almirall

Glenmark's 100% subsidiary Ichnos Sciences Inc., a global biotechnology company developing innovative biologics in oncology and autoimmune diseases, and Almirall S.A, a global biopharmaceutical company focused on skin health, announced today that they have entered into an exclusive licensing agreement for the IL-1RAP antagonist ISB 880

Outsourcing | 14/12/2021 | By Darshana

Natco Pharma's partner Breckenridge Pharma launches generic Afinitor in US market

Natco Pharma's partner Breckenridge Pharma launches generic Afinitor in US market

Natco Pharma Limited announced that its marketing partner Breckenridge Pharmaceutical, Inc., US has launched the 10mg strength of everolimus tablets (generic for Afinitor) in the US market

Outsourcing | 01/10/2021 | By Darshana

ICMR invites proposals for providing clinical trials liability insurance for SOLIDARITY PLUS trial

ICMR invites proposals for providing clinical trials liability insurance for SOLIDARITY PLUS trial

ICMR through ICMR-National AIDS Research Institute, Pune is coordinating a trial, titled "An international randomized trial of additional treatments for Covid-19 in hospitalized patients who are all receiving the local standard of care SOLIDARITY TRIAL PLUS" or World Health Organization (WHO)-India (ICMR) SOLIDARITY trial plus

Outsourcing | 27/08/2021 | By Darshana 110

DoP extends timeline for submission of applications under PLI scheme for KSMs, APIs & medical devices

DoP extends timeline for submission of applications under PLI scheme for KSMs, APIs & medical devices

The Department of Pharmaceuticals (DoP) has extended the timeline for submission of applications under the production linked incentive scheme for promotion of domestic manufacturing of critical key starting materials (KSMs) or drug intermediates and active pharmaceutical ingredients (API) and medical devices, till August 31, 2021

Outsourcing | 30/07/2021 | By Darshana 121

Pharmexcil seeks details on market access challenges faced by exporters in 8 regions including US, EU, Japan

Pharmexcil seeks details on market access challenges faced by exporters in 8 regions including US, EU, Japan

In a bid to enhance market access for Indian pharmaceuticals, the Pharmaceuticals Export Promotion Council of India (Pharmexcil) has asked its member companies to furnish details of market access issues and non-tariff measures (NTMs) being faced them while exporting to countries like United States of America, European Union, Japan, Australia, Brazil

Outsourcing | 15/07/2021 | By Darshana

VectorBuilder and Univercells Technologies announce strategic partnership for optimized custom viral vector production

VectorBuilder and Univercells Technologies announce strategic partnership for optimized custom viral vector production

VectorBuilder a global leader in vector design, optimization and GMP manufacturing has formed a worldwide strategic partnership with Univercells Technologies, a provider of novel biomanufacturing technologies for flexible and scalable viral vector production

Outsourcing | 06/07/2021 | By Darshana

DRDO invites EoI to transfer technology of 2-DG drug for bulk production

DRDO invites EoI to transfer technology of 2-DG drug for bulk production

The Defence Research and Development Organisation (DRDO), which developed 2-Deoxy-D-Glucose (2-DG), a drug used for treatment of Covid-19 patients, has called for Expression of Interest (EoI) to transfer the technology to Indian pharmaceutical industries for production

Outsourcing | 10/06/2021 | By Darshana

FDA Updates Analysis of Medical Device Reports of Breast Implant Illness and Breast Implant-Associated Lymphoma

FDA Updates Analysis of Medical Device Reports of Breast Implant Illness and Breast Implant-Associated Lymphoma

Today, the U.S. Food and Drug Administration is providing an update on adverse events reported to the Agency related to breast implants, including breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), and systemic signs and symptoms referred to by patients as breast implant illness (BII), which some patients report after receiving breast

Outsourcing | 21/08/2020 | By Darshana 431


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology